Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Imaging biochemical recurrence after prostatectomy: Where are we headed?
Peeyush Bhargava
, Gregory Ravizzini
, Brian F. Chapin
, Vikas Kundra
Radiology
Research output
:
Contribution to journal
›
Review article
›
peer-review
26
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Imaging biochemical recurrence after prostatectomy: Where are we headed?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Prostatectomy
100%
Biochemical Recurrence
100%
Multiparametric MRI (mpMRI)
100%
Prostate-specific Antigen
50%
Positron Emission Tomography-computed Tomography (PET-CT)
50%
Metastatic Disease
50%
PET-MRI
50%
Clinical Trials
25%
Recurrent Disease
25%
Low Risk
25%
Multiple Imaging Modalities
25%
High Risk
25%
Imaging Modalities
25%
Distant Metastasis
25%
Local Recurrence
25%
Salvage Treatment
25%
Pelvic Lymph Nodes
25%
CT Studies
25%
Regional Lymph Nodes
25%
Postsurgical
25%
Regional Metastasis
25%
Bone Recurrence
25%
Patients with Prostate Cancer
25%
One-stop-shop
25%
Metastasis Risk
25%
Evolving Roles
25%
Total-body PET/CT
25%
Disease Evaluation
25%
Evaluation Trial
25%
11C-choline
25%
Prostate Bed
25%
18F-fluciclovine
25%
Lymph Node Recurrence
25%
Medicine and Dentistry
Magnetic Resonance Imaging
100%
Prostatectomy
100%
Biochemical Recurrence
100%
Recurrent Disease
75%
Metastatic Carcinoma
75%
Lymph Node
50%
Positron Emission Tomography-Computed Tomography
50%
Positron Emission Tomography - Magnetic Resonance Imaging
50%
Prostate Specific Membrane Antigen
50%
Clinical Trial
25%
Prostate Cancer
25%
Pelvis
25%
Distant Metastasis
25%
Biopsy Technique
25%
Choline
25%
Whole Body PET
25%
Carbon 11
25%
Gallium 68
25%
Fluciclovine F 18
25%
Pharmacology, Toxicology and Pharmaceutical Science
Biochemical Recurrence
100%
Polyethylene Terephthalate
100%
Recurrent Disease
75%
Prostate Specific Membrane Antigen
50%
Clinical Trial
25%
Prostate Cancer
25%
Distant Metastasis
25%
Choline
25%
Carbon 11
25%
Fluciclovine F 18
25%
Gallium 68
25%